When and How to Use Immunomodulators and Biologics in IBD
Dedicated to the interests of the entire community of patients with inflammatory bowel disease (IBD), and designed to meet the educational needs of all healthcare professionals who treat and manage patients with IBD, 2015 Advances in Inflammatory Bowel Diseases: Crohn's & Colitis Foundation's Clinical and Research Conference is the foremost event for investigators and healthcare professionals to come together, share their knowledge and experience, and learn about the latest advances and new insights for personalized care of patients with IBD.
In this presentation, Dr. Gary R. Lichtenstein discusses when and how to use immumodulators and biologics in the treatment of IBD.
Earn accreditation for this activity at the following location:
http://elc.imedex.com/elc/activity-search.aspx?search=2015AIBDWEBCAST
© 2016 Imedex, LLC.
Видео When and How to Use Immunomodulators and Biologics in IBD канала HMP Education
In this presentation, Dr. Gary R. Lichtenstein discusses when and how to use immumodulators and biologics in the treatment of IBD.
Earn accreditation for this activity at the following location:
http://elc.imedex.com/elc/activity-search.aspx?search=2015AIBDWEBCAST
© 2016 Imedex, LLC.
Видео When and How to Use Immunomodulators and Biologics in IBD канала HMP Education
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
The Patient Centered IBD Medical Home: Will This be the Future of IBD Healthcare Delivery?
Key Insights: Updates in Colorectal Cancer
Do we have reliable biomarkers to guide use of immunotherapy agents?
Key Insights: Novel Targets for IBD Therapy - Is This the Final Frontier?
Segment 2: Risk Assessment in Prostate Cancer
Autoimmunity in CLL
Mechanisms of Angiogenesis Inhibitors in Metastatic Colorectal Cancer
Virtual Patient Case: Carcinoid Syndrome #1 - Initial Presentation
Challenges Facing Medical Oncology Practice in the Next Decade
New agents/strategies on the horizon in bile duct cancer
What Determines “Quality” for Endoscopy Reporting in IBD Patients?
Optimizing Lumbar Discectomy: Closing Holes in the Disc
Expert Perspectives: MPN and MDS
Molecular Alterations and New Drugs in Bile Duct Cancer
Testing for BRCA Germline Mutations in the Clinic and the Mechanism of Action of PARP Inhibitors
Update on dysplasia detection: Should you use chromoendoscopy?
Multiple Myeloma Update: Maintenance Therapy
The Current Landscape of Biosimilars in IBD
Picking a Treatment Target: Is it as “Simple” as Mucosal Healing?
Optimizing Biological Therapies in the Modern Era
Key Insights in Chronic Lymphocytic Leukemia